Literature DB >> 26162027

Small Musculoskeletal Soft-Tissue Lesions: US-guided Core Needle Biopsy--Comparative Study of Diagnostic Yields according to Lesion Size.

Sang Yoon Kim1, Hye Won Chung1.   

Abstract

PURPOSE: To determine the effectiveness of ultrasonographically (US) guided core needle biopsy (CNB) for diagnosis of small musculoskeletal soft-tissue lesions by demonstrating the noninferiority of the diagnostic yield with US-guided CNB in lesions measuring 2 cm or smaller to that for lesions larger than 2 cm.
MATERIALS AND METHODS: This retrospective study was institutional review board approved, and the requirement to obtain informed consent was waived. Five hundred US-guided CNBs performed for diagnosis of musculoskeletal soft-tissue lesions were included. Results of US-guided CNBs were divided into four categories, and the diagnostic yields were calculated on the basis of lesion size. A one-sided 97.5% confidence interval was calculated to determine the mean difference in diagnostic yields to test for noninferiority. In addition, the diagnostic yield with US-guided CNBs for lesions 1 cm or smaller was compared with that for lesions larger than 1 cm.
RESULTS: A total of 500 technically successful US-guided CNBs in 494 patients with musculoskeletal soft-tissue lesions who underwent subsequent surgical excision or at least 6 months of follow-up were included. The diagnostic yields with US-guided CNB were 87% for lesions larger than 2 cm and 88% for lesions 2 cm or smaller. The lower bound of the confidence interval was -0.07, thus the noninferiority of the diagnostic yield with CNB for lesions 2 cm or smaller to that for lesions larger than 2 cm was shown. On the other hand, the diagnostic yield with US-guided CNB for lesions 1 cm or smaller was inferior to that for lesions larger than 1 cm.
CONCLUSION: US-guided CNB of musculoskeletal soft-tissue lesions is effective for diagnosis and decision making, even in lesions measuring 2 cm or smaller. However, when a lesion is 1 cm or smaller, US-guided CNB is more frequently insufficient for histopathologic diagnosis. © RSNA, 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26162027     DOI: 10.1148/radiol.2015142516

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Efficacy of image-guided synovial biopsy.

Authors:  T Conor McKee; Jeffrey A Belair; Keenan Sobol; Scot A Brown; John Abraham; William Morrison
Journal:  Skeletal Radiol       Date:  2020-01-07       Impact factor: 2.199

2.  Ultrasound-guided Biopsy of Musculoskeletal Soft-tissue Tumors: Basic Principles, Usefulness and Limitations.

Authors:  Violeta Vasilevska Nikodinovska; Slavcho Ivanoski; Slavica Kostadinova-Kunovska; Milan Samardziski
Journal:  J Ultrason       Date:  2022-04-27

3.  Accuracy of ultrasound in the characterization of superficial soft tissue tumors: a prospective study.

Authors:  Esther H Y Hung; James F Griffith; Stefanie W Y Yip; Marina Ivory; Jeremiah C H Lee; Alex W H Ng; Cina S L Tong
Journal:  Skeletal Radiol       Date:  2020-01-03       Impact factor: 2.199

4.  The safety of primary surgical excision of small deep indeterminate musculoskeletal soft tissue masses.

Authors:  Michèle Calleja; Qasim Afzaal; Asif Saifuddin
Journal:  Br J Radiol       Date:  2020-10-30       Impact factor: 3.039

5.  Practical Guidelines for Ultrasound-Guided Core Needle Biopsy of Soft-Tissue Lesions: Transformation from Beginner to Specialist.

Authors:  Sang Yoon Kim; Hye Won Chung; Tack Sun Oh; Jong-Seok Lee
Journal:  Korean J Radiol       Date:  2017-02-07       Impact factor: 3.500

6.  The diagnostic value of ultrasound-guided percutaneous core needle biopsy of musculoskeletal soft tissue lesions.

Authors:  Paweł Szaro; Andrew Wong; Elena Blain; Khaldun Ghali Gataa; Mats Geijer
Journal:  J Ultrason       Date:  2021-03-08

7.  Small Subcutaneous Soft Tissue Tumors (<5 cm) Can Be Sarcomas and Contrast-Enhanced Ultrasound (CEUS) Is Useful to Identify Potentially Malignant Masses.

Authors:  Armanda De Marchi; Simona Pozza; Lorena Charrier; Filadelfo Cannone; Franco Cavallo; Alessandra Linari; Raimondo Piana; Irene Geniò; Paolo Balocco; Alessandro Massè
Journal:  Int J Environ Res Public Health       Date:  2020-11-28       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.